Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Argenx, Ascentage, Astellas, Astrazeneca, Ausper, Ausperbio, Drug Farm, Harbour, Iaso, Innovent, Invivyd, Kazia, Moderna, Recce, Sihuan, Skyline, Specialised, Transcenta, Xuanzhu, Zai Lab.